We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for nelarabine (Reach Pharmaceuticals Pty Ltd)
Active ingredients
nelarabine
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Solution for infusion
Indication
Treatment of patients with t-cell acute lymphoblastic leukemia and t-cell lymphoblastic lymphoma
Therapeutic area
Haematology